David Thomas Tao is an NYC-based spirits reviewer, writer, entrepreneur, and Tony-nominated producer. A Kentucky native, Kentucky Colonel, and Forbes 30 Under 30 listmaker, his passion for drinks ...
For weeks, Bell Potter Securities’ Richard Coppleson has warned readers of his popular after-market newsletter that all the ingredients were laid out for “the mother of all short squeezes” on Wall ...
At first blush, the biggest rally for US stocks in more than 10 months suggests investors on Tuesday were suddenly overwhelmed by optimism that the Iran war would be ending soon. Yet there was ...
Another round down, another record number of votes. We’re through the Sweet Sixteen in our 2026 Whiskey Riff Madness tournament, and in each round so far we’ve set a record for most votes in a single ...
Forbes contributors publish independent expert analyses and insights. You can find me at the confluence of food, beverage and travel. New Riff's Bottled In Bond Kentucky Straight Bourbon was crowned ...
Biotech and software are the two most heavily-shorted sectors, it seems The last thing investors are thinking about right now -- as Wall Street wrestles with surging oil prices -- is a short squeeze.
Managers are taking on broader responsibilities amid organizational flattening and efficiency pushes. This means less time for training junior employees — and an emphasis on hiring those with greater ...
I last covered Nebius Group N.V. (NBIS) on Feb 16 with an article titled “Nebius Group Q4 Earnings: My CliffsNotes On Revenue Recognition.” The article served as a review of its FQ4 earnings report ...
EchoStar (SATS) entered the S&P 500 with 21.5% short interest and days to cover at 7.68, creating sustained structural buying pressure from passive index funds that shorts cannot easily outrun; shares ...
Curious from birth, Fiona is a music writer, researcher, and cultural theorist based in the UK. She studied her Bachelor of Music in London, specializing in audiovisual practices, and progressed to a ...
Rhys Parry is a research fellow in the School of Chemistry and Molecular Biosciences at the University of Queensland in Brisbane, Australia. I didn’t set out to build a career on other people’s data.